Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Andreas P. Wagner Sells 14,878 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Andreas P. Wagner sold 14,878 shares of Alignment Healthcare stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $14.38, for a total transaction of $213,945.64. Following the completion of the sale, the insider now owns 200,885 shares in the company, valued at approximately $2,888,726.30. This trade represents a 6.90 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Alignment Healthcare Trading Down 1.4 %

ALHC stock traded down $0.19 during mid-day trading on Friday, hitting $13.68. The company had a trading volume of 1,222,559 shares, compared to its average volume of 2,003,122. The stock's fifty day moving average price is $12.95 and its two-hundred day moving average price is $11.61. Alignment Healthcare, Inc. has a 12 month low of $4.46 and a 12 month high of $15.82. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60.

Wall Street Analyst Weigh In

ALHC has been the topic of several recent research reports. Barclays upped their price objective on Alignment Healthcare from $7.00 to $8.00 and gave the stock an "underweight" rating in a report on Wednesday, October 30th. Stifel Nicolaus boosted their price objective on Alignment Healthcare from $14.00 to $16.00 and gave the company a "buy" rating in a research report on Tuesday, January 14th. UBS Group upped their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a "neutral" rating in a research note on Wednesday, October 30th. Finally, Stephens restated an "overweight" rating and set a $17.00 price target on shares of Alignment Healthcare in a report on Thursday, January 2nd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $11.88.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Creative Planning raised its position in shares of Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company's stock valued at $147,000 after buying an additional 2,072 shares during the last quarter. Rhumbline Advisers grew its position in Alignment Healthcare by 2.2% during the 4th quarter. Rhumbline Advisers now owns 135,704 shares of the company's stock worth $1,527,000 after purchasing an additional 2,937 shares during the period. MetLife Investment Management LLC lifted its stake in Alignment Healthcare by 5.6% in the 4th quarter. MetLife Investment Management LLC now owns 61,344 shares of the company's stock valued at $690,000 after buying an additional 3,256 shares in the last quarter. Alliancebernstein L.P. raised its holdings in Alignment Healthcare by 2.8% in the 4th quarter. Alliancebernstein L.P. now owns 119,440 shares of the company's stock valued at $1,344,000 after acquiring an additional 3,300 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. grew its position in Alignment Healthcare by 15.0% in the 4th quarter. Adage Capital Partners GP L.L.C. now owns 34,497 shares of the company's stock valued at $388,000 after acquiring an additional 4,497 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.